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LETTERS TO THE EDITOR
Rescue Angioplasty After
Failed Thrombolysis—High
Mortality Despite Successful Procedure
Ross et al. (1) have presented the largest prospective and prespeci-
fied series to date of rescue angioplasty procedures, which is of
considerable interest. One important point should be made.
In the text they state the following:
“Patients with successful thrombolysis had the lowest 30-
day mortality rate, followed by those with successful rescue
PTCA and those in whom no rescue was attempted.”
It is hard to reconcile this statement with Figure 1, which depicts
30-day mortality rates in the successful rescue group and conser-
vatively treated lytic failure group of 8.6% and 7.9% respectively.
One of the major controversies concerning rescue angioplasty is
the distressingly high mortality rate following a failed rescue
attempt. Unfortunately, the 30-day mortality after successful
rescue angioplasty in this series is also uncomfortably high. At least
two features of rescue angioplasty will be required before the
strategy is universally accepted. First, failed rescue angioplasty
should be a rare event. It is possible that the use of coronary artery
stents, intraaortic balloon pumping and glycoprotein IIb/IIIa
inhibitors will facilitate this. Second, the mortality rate following a
successful attempt should be considerably lower than that of
patients receiving conservative treatment for a persistently oc-
cluded IRA. Ross et al. (1) do not provide convincing evidence that
the latter is true.
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REPLY
Dr. Sutton’s reading of our manuscript is ever so slightly different
from the intended meaning, which was that 8.6% and 7.9% are not
different (statistically), as opposed to indicating a progression (or
decrement).
We, of course, agree that higher success rates for rescue
percutaneous transluminal coronary angioplasty (PTCA) are de-
sirable and are probably now being achieved with improving tools
and techniques. We reiteriate that an almost certain selection bias
resulted in rescues being attempted in a higher risk group than
those left with a closed artery. It is also our feeling that much
earlier identification and angioplasty for failed thrombolysis will
be necessary to further improve the outcome in such patients.
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Transfer delay for primary PTCA:
Does it Influence Clinical Outcome?
In Liem et al.’s (1) article on the effect of transfer delay on infarct
size and clinical outcome in patients who are referred for primary
percutaneous transluminal coronary angioplasty (PTCA), they
compared a cohort of 207 patients transferred from other hospitals
with a matched group of 207 patients directly admitted to a PTCA
center. The difference between the two cohorts in time delay from
onset of symptoms to PTCA was a transfer delay of median
43 min, and time from symptom onset, infarct location, age,
gender and Killip class were similar. Transfer delay was associated
with a larger infarct size and lower ventricular function, albeit with
similar patency rates. Despite these adverse effects on myocardial
salvage, clinical outcome after six months has reported to be not
adversely affected, i.e., 7% versus 6% mortality and 4% versus 3%
nonfatal reinfarction. We object, however, to the authors’ conclu-
sion that “6-month clinical outcome [was] not affected by this
[transfer] delay.” Such a conclusion cannot be drawn from this
study, because the sample size of 414 patients was too small. For
instance, the hypothesis that a mortality difference between trans-
ferred and nontransferred patients would not exceed 2% from an
expected 6% mortality rate would require more than 3,400 patients
in each treatment group, when tested by a two-tailed chi-square
test with alpha 0.05 and beta 0.10. The authors would be correct
only when a difference in mortality of 10% was accepted as not
clinically important, but such a difference is not considered
ethically acceptable. Therefore, the adage “time is muscle” still
holds for patients considered for primary PTCA, but a larger study
should be conducted before conclusions can be drawn about the
effects of transfer delay on clinical outcome in patients referred for
primary PTCA.
A second item we wish to discuss is the time frame within which
patients may still be transferred to a PTCA center. The possible
benefit of myocardial salvage will decrease with increasing time,
and additional delay by transfer of patients in this stage may not be
desirable. It seems from this study that all patients were presented
to the hospital within 3 h (Table 1). For this reason, myocardial
salvage difference between the transferred and nontransferred was
found to be large. It would be interesting if the authors could
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